The health care and FDA practice unit of Greenberg Traurig in Denver, Colorado has welcomed two new members to its team, Erin M. Eiselein and Anna-Liisa Mullis, who join the firm as shareholders. The news was announced by the firm on Thursday.
Eiselein brings extensive expertise to the firm, providing advice on health care regulatory and operational issues and litigating complex disputes. Her previous clients include hospital systems, ambulatory surgery centers, and health care providers.
Similarly, Mullis comes with a strong background in addressing operational, regulatory, and privacy issues. Her experience extends to representing health care clients in complex litigation matters.
Furthermore, Ishra K. Solieman joins Eiselein and Mullis from Brownstein Hyatt Farber Schreck, taking on the role of ‘of counsel’ at Greenberg Traurig.
This recent expansion underscores Greenberg Traurig’s well-established commitment to providing comprehensive legal guidance in the health care and FDA sector. The addition of Eiselein, Mullis, and Solieman to their team indicates their strategic plan for ensuring top-notch service to their clients.
For the original report, see this article by Bloomberg Law Automation.